Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Athena Therapeutics has closed an initial financing round with HighCape Capital and Connecticut Innovations. Utilizing discoveries and intellectual property licensed from Yale University, Athena plans...
Founded in 2019, Allyx Therapeutics is a biotechnology company based in New Haven, CT, developing new therapies to protect synapses from destruction in Alzheimer’s disease...
Arvinas, a biotechnology company developing two cancer-fighting drugs, recently raised $400 million in a stock offering. After the company released clinical data regarding testing of its...
New Haven investor David Goldblum has won city permission to convert an eight-story office building at 55 Church Street into new laboratory an research space. “New Haven...
The coronavirus vaccine made by Moderna has moved closer to FDA authorization. Moderna would be the second company allowed to begin inoculating the U.S. public,...
Over the fall semester, UConn has administered or tracked more than 42,000 COVID-19 individual and surveillance tests among its student body, helping it successfully complete...
Svigals + Partners, LLP is a full-service architecture firm offering architectural, master planning, interior design and FFE services. With nearly 40 years of professional experience,...
Boehringer Ingelheim plans to acquire NBE-Therapeutics, a private, clinical-stage Swiss biotechnology company focused on antibody-drug conjugates and advancing targeted cancer therapies derived from its immune stimulatory iADC™...
Recently released data confirm that Moderna’s coronavirus vaccine is highly protective, setting the stage for its emergency authorization this week by federal regulators and the...
Thetis Pharmaceuticals has received an FDA orphan drug designation for TP-317 as a small molecule, oral therapy for treatment of pediatric ulcerative colitis. “We are pleased...